diaDexus Company Profile (OTCMKTS:DDXS)

About diaDexus (OTCMKTS:DDXS)

diaDexus logoDiadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:DDXS
  • CUSIP: N/A
  • Web: www.diadexus.com/
Average Prices:
  • 50 Day Moving Avg: $1.00
  • 200 Day Moving Avg: $2.00
  • 52 Week Range: $0.01 - $5.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.01
  • P/E Growth: 0
  • Net Margins: -47.79%
  • Return on Assets: -58.13%
  • Average Volume: 24,020 shs.

Frequently Asked Questions for diaDexus (OTCMKTS:DDXS)

What is diaDexus' stock symbol?

diaDexus trades on the OTCMKTS under the ticker symbol "DDXS."

How were diaDexus' earnings last quarter?

diaDexus, Inc. (OTCMKTS:DDXS) announced its quarterly earnings data on Monday, October, 26th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.69) by $0.35. View diaDexus' Earnings History.

Who are some of diaDexus' key competitors?

Who are diaDexus' key executives?

diaDexus' management team includes the folowing people:

  • Lori F. Rafield Ph.D., Chairman of the Board, Chief Executive Officer
  • Leone D. Patterson, Chief Financial Officer
  • Emi Zychlinsky Ph.D., Executive Vice President, Chief Technology Officer
  • Christopher P. Lowe, Chief Accounting Officer
  • Jonathan Ruais, Vice President of Marketing
  • Kenneth C. Fang M.D., Chief Medical Officer
  • R. Michael Richey, Chief Business Officer
  • James R. Sulat, Director
  • John T. Curnutte M.D. Ph.D., Independent Director
  • Karen Drexler, Independent Director

How do I buy diaDexus stock?

Shares of diaDexus can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is diaDexus' stock price today?

One share of diaDexus stock can currently be purchased for approximately $0.01.

MarketBeat Community Rating for diaDexus (OTCMKTS DDXS)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  112
MarketBeat's community ratings are surveys of what our community members think about diaDexus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for diaDexus (OTCMKTS:DDXS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for diaDexus (OTCMKTS:DDXS)
Price Target History for diaDexus (OTCMKTS:DDXS)
Analysts' Ratings History for diaDexus (OTCMKTS:DDXS)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for diaDexus (OTCMKTS:DDXS)
Earnings by Quarter for diaDexus (OTCMKTS:DDXS)
Earnings History by Quarter for diaDexus (OTCMKTS DDXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2015($0.69)($0.34)ViewN/AView Earnings Details
8/13/2015($0.29)($0.87)ViewN/AView Earnings Details
5/12/2015Q115($0.04)($0.02)$5.23 millionViewN/AView Earnings Details
3/11/2015($0.02)($0.04)ViewN/AView Earnings Details
11/5/2014($0.01)($0.03)ViewN/AView Earnings Details
7/28/2014($0.02)($0.01)ViewN/AView Earnings Details
5/7/2014($0.03)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for diaDexus (OTCMKTS:DDXS)
Current Year EPS Consensus Estimate: $-1.50 EPS
Next Year EPS Consensus Estimate: $-1.50 EPS


Dividend History for diaDexus (OTCMKTS:DDXS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for diaDexus (OTCMKTS:DDXS)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for diaDexus (OTCMKTS:DDXS)
Latest Headlines for diaDexus (OTCMKTS:DDXS)
Loading headlines, please wait.



diaDexus (DDXS) Chart for Tuesday, October, 24, 2017

This page was last updated on 10/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.